Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients
NCT ID: NCT06647849
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2024-11-11
2027-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Early pregnancy loss can have major psychological consequences for the woman, her partner and the couple in the aftermath, as well as on the experience and progress of a future pregnancy.
In France, the vast majority of miscarriages are diagnosed in gynecological emergencies by interns still in training. Interns, sometimes at the beginning of their training, may find it difficult to announce a miscarriage, and may do so in a way that is clumsy or not adapted to the woman's emotions, which can lead to a bad experience for her. This bad experience could lead to psychological distress, post-traumatic stress and/or impair future fertility.
The initiators of this project have already carried out a before-and-after, single-center study, showing a significant improvement in the specific Perinatal Grief Scale score following specific training for interns in first-trimester pregnancy loss.
To date, no multicenter randomized study has been conducted to assess the impact of first-trimester pregnancy loss on women's psychological experience.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Place of Men in Arrested Pregnancies
NCT05208645
Psychatric Impact of Miscarriage in Assiut University Hospital
NCT05579756
Machine Learning Miscarriage Management Clinical Decision Support Tool Study
NCT06384144
Antenatal Palliative Care
NCT03795857
Feasibility Study of a Coping Intervention for Recurrent Miscarriage
NCT02989220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm "with training"
Arm "with training": centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases.
centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases
The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement.
This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.
"Untrained" arm
"Untrained" arm: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department.
centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department
In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation.
During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases
The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement.
This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.
centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department
In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation.
During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient presenting to gynaecological emergency department
* Patient with a diagnosis of terminated pregnancy or spontaneous expulsion of a pregnancy \< 14 weeks' amenorrhea
* Patient whose spontaneous miscarriage was announced by an intern
* Patient affiliated to or benefiting from a social security scheme
* Patient having signed an informed consent form
Exclusion Criteria
* Spontaneous hemorrhagic miscarriage requiring surgical management
* Ectopic pregnancy
* Miscarriage resulting from assisted reproduction treatment
* Patient with history of miscarriage ≥ 3
* Poor understanding of the French language
* Person deprived of liberty by judicial or administrative decision
* Person under forced psychiatric care
* Person subject to a legal protection measure
* Person unable to give consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Générale de l'Offre de Soins
OTHER_GOV
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Legendre, MD, PhD
Role: STUDY_DIRECTOR
University Hospital of Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Amiens
Amiens, , France
University Hospital of Angers
Angers, , France
University Hospital of Bordeaux
Bordeaux, , France
University Hospital of Brest
Brest, , France
Femme Mere Enfant Hospital
Bron, , France
University Hospital of Caen
Caen, , France
CH Chalon-sur-Saône
Chalon-sur-Saône, , France
CH Cholet
Cholet, , France
University Hospital of Clermont-Ferrand
Clermont-Ferrand, , France
University Hospital of Dijon
Dijon, , France
CHU Grenoble
Grenoble, , France
Vendée Departmental Hospital center
La Roche-sur-Yon, , France
Le Mans Hospital
Le Mans, , France
Jeanne de Flandre Hospital
Lille, , France
University Hospital of Limoges
Limoges, , France
Hopital Nord (Marseille Public University Hospital System)
Marseille, , France
La Conception Hospital (Marseille Public University Hospital System)
Marseille, , France
University Hospital of Montpellier
Montpellier, , France
University Hospital of Nancy
Nancy, , France
University Hospital of Nantes
Nantes, , France
CHU Nice
Nice, , France
University Hospital of Nimes
Nîmes, , France
CHU Orléans
Orléans, , France
Poissy intercommunal hospital center
Poissy, , France
University Hsopital of Reims
Reims, , France
University Hospital of Rennes
Rennes, , France
University Hospital of Rouen
Rouen, , France
University Hospital of Saint Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Loic Sentilhes
Role: primary
Karine MORCEL
Role: primary
Charles-André PHILIP
Role: primary
Mariette BRUAND
Role: primary
Thierry MICHY
Role: primary
Jérôme DELOTTE
Role: primary
Hélène GBAGUIDI
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A01244-43
Identifier Type: OTHER
Identifier Source: secondary_id
49RC21_0257
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.